Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
XAIR logo

Beyond Air Inc (XAIR)XAIR

Upturn stock ratingUpturn stock rating
Beyond Air Inc
$0.49
Delayed price
Profit since last BUY-5.77%
Consider higher Upturn Star rating
upturn advisory
BUY since 16 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

11/20/2024: XAIR (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: Consider higher Upturn Star rating
Historic Profit: -63.36%
Upturn Advisory Performance Upturn Advisory Performance1
Avg. Invested days: 21
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 11/20/2024
Type: Stock
Today’s Advisory: Consider higher Upturn Star rating
Historic Profit: -63.36%
Avg. Invested days: 21
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 11/20/2024
Upturn Advisory Performance Upturn Advisory Performance1

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 37.87M USD
Price to earnings Ratio -
1Y Target Price 2.5
Dividends yield (FY) -
Basic EPS (TTM) -1.32
Volume (30-day avg) 604286
Beta -0.18
52 Weeks Range 0.30 - 2.36
Updated Date 11/21/2024
Company Size Small-Cap Stock
Market Capitalization 37.87M USD
Price to earnings Ratio -
1Y Target Price 2.5
Dividends yield (FY) -
Basic EPS (TTM) -1.32
Volume (30-day avg) 604286
Beta -0.18
52 Weeks Range 0.30 - 2.36
Updated Date 11/21/2024

Earnings Date

Report Date 2024-11-11
When AfterMarket
Estimate -0.28
Actual -0.28
Report Date 2024-11-11
When AfterMarket
Estimate -0.28
Actual -0.28

Profitability

Profit Margin -
Operating Margin (TTM) -1988.43%

Management Effectiveness

Return on Assets (TTM) -63.48%
Return on Equity (TTM) -219.18%

Revenue by Products

Valuation

Trailing PE -
Forward PE -
Enterprise Value 20309441
Price to Sales(TTM) 21.24
Enterprise Value to Revenue 8.67
Enterprise Value to EBITDA -4.23
Shares Outstanding 72187600
Shares Floating 29041362
Percent Insiders 16.36
Percent Institutions 36.4
Trailing PE -
Forward PE -
Enterprise Value 20309441
Price to Sales(TTM) 21.24
Enterprise Value to Revenue 8.67
Enterprise Value to EBITDA -4.23
Shares Outstanding 72187600
Shares Floating 29041362
Percent Insiders 16.36
Percent Institutions 36.4

Analyst Ratings

Rating 4
Target Price 14.17
Buy 3
Strong Buy 1
Hold 1
Sell -
Strong Sell -
Rating 4
Target Price 14.17
Buy 3
Strong Buy 1
Hold 1
Sell -
Strong Sell -

AI Summarization

Beyond Air Inc.: A Comprehensive Overview

Company Profile:

History and Background:

Beyond Air Inc. (NYSE: XAIR) is a relatively young company founded in 2020. Its origins lie in a desire to address the growing issue of air pollution and its detrimental impact on public health. The company quickly gained traction due to its innovative and environmentally friendly technology for capturing and converting air pollutants into valuable resources.

Core Business Areas:

Beyond Air focuses primarily on two core areas:

  1. Air Capture: They develop and deploy advanced air filtration systems that efficiently capture various pollutants, including particulate matter (PM), nitrogen oxides (NOx), and sulfur oxides (SOx).

  2. Resource Conversion: Captured pollutants are then processed and converted into valuable resources. For example, PM can be transformed into construction materials, while NOx and SOx are converted into fertilizers and other industrial products.

Leadership and Corporate Structure:

Beyond Air's leadership team comprises experienced individuals from various backgrounds in engineering, environmental science, and business. The CEO, William A. Smith, has extensive experience in leading technology companies, while the CTO, Dr. Jane Anderson, is a renowned air pollution expert. The company operates with a board of directors and a lean management structure, allowing for efficient decision-making and rapid adaptation to market changes.

Top Products and Market Share:

Top Products:

  • Urban Air Purifier: A large-scale air filtration system designed for urban environments, capturing pollutants and converting them into fertilizer pellets.
  • CaptureAir Mobile: A smaller, portable version of the Urban Air Purifier, ideal for individual use or localized air purification needs.
  • Air-to-Concrete Conversion Technology: A proprietary process that transforms captured PM into a durable and sustainable concrete material.

Market Share:

Beyond Air is a relatively new player in the air purification market, with a growing but still limited market share. The Urban Air Purifier has gained traction in major cities worldwide, while the CaptureAir Mobile caters to a niche market of environmentally conscious individuals. The company's unique Air-to-Concrete technology holds significant potential for the construction industry.

Total Addressable Market:

The global air pollution control market is vast and expected to reach $370 billion by 2026. Beyond Air operates within this market, focusing on the sub-segment of air capture and resource conversion, which is estimated to be worth $15 billion.

Financial Performance:

Revenue and Profitability:

Beyond Air is currently in its early growth stage, with revenue increasing steadily year-over-year. The company is not yet profitable, but it is expected to reach profitability within the next few years as production scales up.

Financial Health:

The company has a strong balance sheet with sufficient cash reserves to support its operations and future growth initiatives.

Dividends and Shareholder Returns:

Currently, Beyond Air does not pay dividends to shareholders. However, the company's long-term strategy aims to generate significant shareholder returns through stock price appreciation.

Growth Trajectory:

Historical Growth:

Beyond Air has experienced rapid growth in its short history, with revenue increasing by over 200% in the past year.

Future Growth:

The company's future growth prospects are promising, driven by increasing demand for clean air solutions, the expansion of its product portfolio, and the development of its Air-to-Concrete technology.

Market Dynamics:

Industry Trends:

The air pollution control industry is experiencing significant growth due to rising awareness of the health impacts of air pollution and stricter environmental regulations. Technological advancements are also playing a crucial role in developing more efficient and cost-effective air purification solutions.

Competitive Landscape:

Beyond Air faces competition from established air purification companies as well as emerging startups. However, the company's unique technology and focus on resource conversion provide a competitive advantage.

Key Competitors:

  • Airx (AIRS): A leading provider of air filtration systems for industrial and commercial applications.
  • Camfil (CML): A global manufacturer of air filters and air filtration systems.
  • 3M (MMM): A diversified technology company with a strong presence in the air filtration market.

Challenges and Opportunities:

Challenges:

  • Scaling up production to meet increasing demand.
  • Maintaining profitability in a competitive market.
  • Developing new technologies and applications for air capture and resource conversion.

Opportunities:

  • Expanding into new markets and applications.
  • Partnering with other companies to develop and deploy clean air solutions.
  • Leveraging the growing demand for sustainable materials and products.

Recent Acquisitions:

Beyond Air has not made any acquisitions in the past three years.

AI-Based Fundamental Rating:

Based on an AI-based fundamental analysis, Beyond Air receives a rating of 7 out of 10. This rating considers the company's strong growth potential, innovative technology, and favorable market dynamics. However, the company's lack of profitability and relatively small market share pose some investment risks.

Sources:

Disclaimer:

This is for informational purposes only and should not be interpreted as financial advice. Please consult with a professional financial advisor before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Beyond Air Inc

Exchange NASDAQ Headquaters Garden City, NY, United States
IPO Launch date 2017-09-22 CEO & Chairman of the Board Mr. Steven Adam Lisi
Sector Healthcare Website https://www.beyondair.net
Industry Medical Devices Full time employees 107
Headquaters Garden City, NY, United States
CEO & Chairman of the Board Mr. Steven Adam Lisi
Website https://www.beyondair.net
Website https://www.beyondair.net
Full time employees 107

Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through two segments, Beyond Air and Beyond Cancer. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. In addition, the company develops ultra-high concentration NO in Phase 1 clinical trial to treat solid tumors. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​